Aria Smart Autoinjector

A Familiar Pen Injector at an Affordable Price
The Envoi Pen Injector is a compact and user-friendly pen device designed for the subcutaneous delivery of medication. It is intended to be used for self-administration of injectable medications, including insulin and glucagon-like peptide-1 (GLP-1)....

The FOX device is a small, handheld, breath-activated, battery-powered inhalation system that delivers nebulized liquid drugs with high performance using a vibrating mesh technology. The device is CE marked and has a 510(k) premarket notification for marketing in the US.

The FOX device is suitab...

• 60-dose DPI device with intuitive user interface • Approved and marketed in the UK, EU and Rest of World

• 60-dose DPI device with four user steps • Approved and marketed in the US

• DPI device with only three user steps • Designed with digital connectivity in mind

• Unit-dose DPI device designed for delivery of higher payload volumes • Incorporates a cyclone design to assist aerosolization for greater lung deposition

Combining the strengths of Phillips Medisize and Vectura enhances our ability to deliver a broader portfolio of innovative inhalation solutions to our pharmaceutical partners and to fulfill our shared vision of helping patients live healthier lives.

Combining the strengths of Phillips Medisize and Vectura enhances our ability to deliver a broader portfolio of innovative inhalation solutions to our pharmaceutical partners and to fulfill our shared vision of helping patients live healthier lives.
Together, we can offer a wider range of formulation, device design and combination product development, as well as manufacturing services to support the growing global need for inhaled therapies to treat chronic respiratory diseases like asthma and COPD, as well as for non-respiratory conditions.

Phillips Medisize is developing an innovative smart autoinjector that is designed to combine the ease of use of a disposable autoinjector with the flexibility of a reusable electronic device.

A Familiar Pen Injector at an Affordable Price

The Envoi Pen Injector is a compact and user-friendly pen device designed for the subcutaneous delivery of medication. It is intended to be used for self-administration of injectable medications, including insulin and glucagon-like peptide-1 (GLP-1). 


The Envoi Pen Injector is an important addition to the Phillips Medisize portfolio, empowering biopharma companies to accelerate the roll out of novel and generic drug treatments with significant economies of scale.

This solution provides the advantages expected from familiar pen designs, while benefiting from decades of our device development expertise and large-volume manufacturing capabilities to reduce the challenge of bringing affordable drugs and delivery devices to market.

In-depth Drug Delivery Device Expertise

Phillips Medisize has the expertise and experience to create design strategies for all stages of development, from clinical trials to small- and large-scale commercial production. With 23 manufacturing facilities and seven R&D innovation centers located across the US, Europe and Asia, we collaborate and deliver to our pharmaceutical customers wherever they are.

We are trusted by leading pharmaceutical, medtech and in vitro diagnostic companies worldwide to design and manufacture their products.

The Phillips-Medisize #Envoi Pen Injector is shown up-close, from every angle and during actual usage. 

The convenient size of this disposable solution makes it ideal for therapies addressing multiple conditions such as diabetes, osteoporosis and infertility. It’s a ready-to-go drug delivery system with a flexible, state-of-the-art design that accommodates variable or fixed dosing needs. 


The highly versatile Envoi Pen Injector enhances patient confidence and comfort with its compact form, minimal elongation and low dosing force. It creates an experience that’s easy and familiar for users—and efficiently adaptable for pharmaceutical manufacturers.

We believe the C in CDMO also represents care – the care we take in engineering your products and the care these devices ultimately deliver to patients.

We are privileged to serve our customers in a tailored, highly personalized way. We listen, ask questions and embrace your engineering challenges. Our 60+ years of expertise and the backing of one of the largest privately held companies in the world allow us to focus on long-term, mutually beneficial solutions for our customers, employees and communities.